Detalhe da pesquisa
1.
A New Quinoline BRD4 Inhibitor Targets a Distinct Latent HIV-1 Reservoir for Reactivation from Other "Shock" Drugs.
J Virol
; 92(10)2018 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29343578
2.
The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy.
Sci Adv
; 9(11): eade6675, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36921041
3.
A Two-Color Haploid Genetic Screen Identifies Novel Host Factors Involved in HIV-1 Latency.
mBio
; 12(6): e0298021, 2021 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34872356
4.
Gliotoxin, identified from a screen of fungal metabolites, disrupts 7SK snRNP, releases P-TEFb, and reverses HIV-1 latency.
Sci Adv
; 6(33): eaba6617, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32851167
5.
A broad drug arsenal to attack a strenuous latent HIV reservoir.
Curr Opin Virol
; 38: 37-53, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31323521
6.
Small Molecule Targeting of Specific BAF (mSWI/SNF) Complexes for HIV Latency Reversal.
Cell Chem Biol
; 25(12): 1443-1455.e14, 2018 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30197195
7.
Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal.
EBioMedicine
; 3: 108-121, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26870822
8.
HIF-regulated HO-1 gene transfer improves the post-ischemic limb recovery and diminishes TLR-triggered immune responses - Effects modified by concomitant VEGF overexpression.
Vascul Pharmacol
; 71: 127-38, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25869523
9.
Arteriogenic therapy based on simultaneous delivery of VEGF-A and FGF4 genes improves the recovery from acute limb ischemia.
Vasc Cell
; 5: 13, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23816205